The report on the Indian coronary intervention data for the year 2011 – National Interventional Council

Ramakrishnan, Sivasubramanian; Mishra, Sundeep; Chakraborty, Rabin; Chandra, K. Sarat; Mardikar, H.M.

doi:10.1016/j.ihj.2013.08.009

Cited by 31 publications

(35 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…are the major determinants in making of this epidemiological picture. Also, as per the report of National Interventional Cardiology (NIC), 2011 for data on Indian coronary heart disease, 13.6% of patients were below 40 years of age [17]. Almost one quarter i.e.…”

Section: Discussionmentioning

confidence: 94%

Retrospective Study of Clinical and Epidemiological Parameters of Patients Undergoing Percutaneous Coronary Intervention with Their Follow-Up

Parikh¹,

Washimkar²,

Deshmukh³

et al. 2019

Open Access Maced J Med Sci

View full text Add to dashboard Cite

AIM: To study clinical and epidemiological parameters of patients undergoing percutaneous coronary intervention (PCI) and to follow them up for understanding the outcomes of the procedure. MATERIAL AND METHODS: This is a retrospective data analysis of 862 patients who underwent PCI from January 2016 to November 2017 RESULTS: Out of 862 patients, 611 (70.88%) were male & 251 (29.12%) were female, with the mean age being 55. 243 (28.19%) were diabetic, 470 (54.52%) were hypertensive, 158 (18.32%) patients were tobacco chewer, 215 (24.92%) were smokers and 111 (12.87%) were alcoholic. 636 (73.78%) patients had STEMI, 153 (17.74%) had NSTE-ACS, 61 (7.07%) had CSA.578 (67.05%) were SVD, 262 (30.39%) were DVD and 19 (2.20%) were TVD. Out of SVD, 350 (60.55%) patients had LAD involvement and among DVD patients, LAD and RCA were most commonly involved in 107 (40.83%) patients. On follow-up of mean 604.42 days (minimum 236 days, maximum 909 days), 2 (0.23%) episodes of subacute stent thrombosis occurred and 11 (1.27%) patients had ISR but no mortality was reported. CONCLUSION: The study shows affection of young population predominately and genders inequality, suggesting primarily male disease. PCI is often sought in ACS and CSA is predominately treated medically. Thrombolysis remains the first treatment received by STEMI patients. SVD is the most common angiographic diagnosis with LAD predominately affected vessel. This real world-data on clopidogrel with aspirin as dual antiplatelet therapy and second-generation stent shows negligible event of stent thrombosis and ISR. LIMITATION: Due to non-invasive follow-up, the exact amount of stent restenosis cannot be calculated. IMPACT ON DAILY PRACTICE: This real world-data on clopidogrel with aspirin as dual antiplatelet therapy and second-generation stent shows negligible event of stent thrombosis and ISR. This can help reduce the cost burden on society and help better distribution of health budget.

show abstract

Section: Discussionmentioning

confidence: 94%

Retrospective Study of Clinical and Epidemiological Parameters of Patients Undergoing Percutaneous Coronary Intervention with Their Follow-Up

Parikh¹,

Washimkar²,

Deshmukh³

et al. 2019

Open Access Maced J Med Sci

View full text Add to dashboard Cite

show abstract

“…In resource-crunched settings like rural India, where Cath Lab facilities are scarce, thrombolytic therapy is still an important part of the early treatment of STEMI. (2,3,4) The advent of percutaneous intervention strategies and advance of bypass graft surgeries has made thrombolysis a very rarely done therapy. In this study, a longterm outcome of thrombolytic therapy was analysed and was found to be of clinical significance.…”

Section: Discussionmentioning

confidence: 99%

Thrombolytic Therapy in Stemi- Relevance in Current World of Interventional Cardiology

K¹,

Mukandan²

2018

jemds

View full text Add to dashboard Cite

BACKGROUND Coronary artery disease is one of the most common non-communicable diseases in India, and acute myocardial infarction has been a leading cause of sudden death in many rural populations in a developing country like ours, where Cath Lab facilities are scarce. Thrombolytic therapy was a major interventional landmark in treatment of STEMI in such resource-crunched settings before the year 2000. MATERIALS AND METHODS In this retrospective observational study, 120 cases of STEMI, treated with thrombolysis in a health care centre in rural part of northern Kerala, during the period of 15 years from 1991-2004, when Interventional Cardiology wasn't popular, were studied. RESULTS It was noticed that 60 patients went on to survive on medical management alone, 30 required PTCA later in life and 10 required CABG later in life. CONCLUSION We conclude that thrombolytic therapy hasn't still lost its importance in a resource-crunched setting where Cath Lab facilities and coronary interventions are still not easily available.

show abstract

“…27 In 2011, >152,000 percutaneous coronary interventions were performed in India with approximately 194,000 stents deployed compared to 40,000 coronary interventions in 2005. 28 In China, data from 2009 suggest that nearly 240,000 percutaneous coronary interventions were performed, with >247,000 stents deployed compared to only about 16,000 percutaneous coronary interventions in 2001. 28-30 The number of people in whom dual antiplatelet therapy is indicated is thus similarly increasing.…”

Section: Rationale For Adding Clopidogrel To the Model List Of Essentmentioning

confidence: 99%

Building the Case for Clopidogrel as a World Health Organization Essential Medicine

Patel

Vidula

Kishore

et al. 2015

Circ: Cardiovascular Quality and Outcomes

View full text Add to dashboard Cite

The report on the Indian coronary intervention data for the year 2011 – National Interventional Council

Cited by 31 publications

References 0 publications

Retrospective Study of Clinical and Epidemiological Parameters of Patients Undergoing Percutaneous Coronary Intervention with Their Follow-Up

Retrospective Study of Clinical and Epidemiological Parameters of Patients Undergoing Percutaneous Coronary Intervention with Their Follow-Up

Thrombolytic Therapy in Stemi- Relevance in Current World of Interventional Cardiology

Building the Case for Clopidogrel as a World Health Organization Essential Medicine

Contact Info

Product

Resources

About